XML 45 R30.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER INCOME
 9 Months Ended
Sep. 30, 2020
Other Income and Expenses [Abstract]  
OTHER INCOME
NOTE 22. OTHER INCOME
Three months ended September 30Nine months ended September 30
(In millions)2020201920202019
Purchases and sales of business interests(a)$21 $46 $12,445 $260 
Licensing and royalty income44 56 117 176 
Associated companies(78)42 (9)163 
Net interest and investment income(b)(582)(29)(4,259)131 
Other items86 37 187 447 
GE$(509)$153 $8,481 $1,177 
Eliminations(8)5 (50)(7)
Total$(517)$158 $8,430 $1,170 
(a)Included a pre-tax gain of $12,362 million on the sale of BioPharma for the nine months ended September 30, 2020. Included a pre-tax gain of $224 million on the sale of ServiceMax for the nine months ended September 30, 2019. See Note 2 for further information.
(b)Included a net pre-tax unrealized loss of $748 million and a pre-tax unrealized loss of $4,613 million for the three and nine months ended September 30, 2020, respectively, related to our interest in Baker Hughes in 2020. Included a pre-tax unrealized loss of $125 million for the three and nine months ended September 30, 2019, related to our interest in Baker Hughes in 2019. See Notes 3 and 21 for further information.